Staidson Beijing Biopharma (300204) — Cash Flow-to-Debt Ratio
Staidson Beijing Biopharma (300204) has a Cash Flow-to-Debt Ratio of -0.10x as of September 2025, meaning its operating cash flow of CN¥-39.18 Million could theoretically repay 0% of its total liabilities (CN¥404.22 Million) in one year. See 300204 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Staidson Beijing Biopharma Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Staidson Beijing Biopharma across 19 annual periods. Also explore Staidson Beijing Biopharma net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Staidson Beijing Biopharma (2007–2025)
Year-by-year debt coverage analysis for Staidson Beijing Biopharma. For market capitalisation and broader financial context, see 300204 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | CN¥-125.68 Million | CN¥459.48 Million | ▼ 0.0% |
| 2024 | -0.27x | CN¥-63.68 Million | CN¥232.85 Million | ▲ +62.5% |
| 2023 | -0.73x | CN¥-227.47 Million | CN¥311.55 Million | ▼ -31.2% |
| 2022 | -0.56x | CN¥-175.60 Million | CN¥315.45 Million | ▲ +5.1% |
| 2021 | -0.59x | CN¥-162.07 Million | CN¥276.25 Million | ▼ -37.6% |
| 2020 | -0.43x | CN¥-114.60 Million | CN¥268.70 Million | ▼ -318.5% |
| 2019 | 0.20x | CN¥44.34 Million | CN¥227.18 Million | ▼ -62.8% |
| 2018 | 0.53x | CN¥165.08 Million | CN¥314.30 Million | ▼ -19.5% |
| 2017 | 0.65x | CN¥273.64 Million | CN¥419.14 Million | ▲ +32.8% |
| 2016 | 0.49x | CN¥212.55 Million | CN¥432.32 Million | ▼ -17.6% |
| 2015 | 0.60x | CN¥231.01 Million | CN¥387.06 Million | ▼ -14.2% |
| 2014 | 0.70x | CN¥206.85 Million | CN¥297.54 Million | ▲ +59.5% |
| 2013 | 0.44x | CN¥111.36 Million | CN¥255.47 Million | ▼ -7.1% |
| 2012 | 0.47x | CN¥90.19 Million | CN¥192.15 Million | ▼ -74.5% |
| 2011 | 1.84x | CN¥87.01 Million | CN¥47.32 Million | ▲ +183.8% |
| 2010 | 0.65x | CN¥63.91 Million | CN¥98.66 Million | ▼ -55.6% |
| 2009 | 1.46x | CN¥42.37 Million | CN¥29.03 Million | ▲ +163.0% |
| 2008 | 0.55x | CN¥16.23 Million | CN¥29.25 Million | ▲ +396.0% |
| 2007 | 0.11x | CN¥5.41 Million | CN¥48.35 Million | — |